PASITHEA THERAPEUTICS CORP. (KTTA)
Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial
Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial
Bendix Selects Aeva to Develop Next-Generation Active Safety Production System for Commercial Vehicles
Cipher Digital Announces Appointment of Bill Blevins as Head of Grid Strategies
Verizon Breaks Industry Mold to Put Customers First
General Announcement: VALUEMAX LAUNCHES SERIES 019 OF 3-MONTH DIGITAL SECURITIES COMMERCIAL PAPER ON THE ADDX EXCHANGE
TransUnion Appoints Clayton Ruebensaal as Chief Marketing and Communications Officer
General Announcement: VALUEMAX LAUNCHES SERIES 013 OF 3-MONTH COMMERCIAL PAPER ON THE SDAX PLATFORM
Management and officers – staffing as of 16.6.26
General Announcement: Boustead Geospatial Division Renews S$60m Geospatial Contract with Significant Uplift
Company presentation Q1 2026